Edit
Petros Pharmaceuticals (formerly Metuchen Pharmaceuticals)
http://petrospharma.com/Last activity: 13.07.2023
Petros is committed to becoming the world’s leading men’s health company by identifying, developing, acquiring and commercializing innovative therapeutics for men’s health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie’s disease (acute and chronic), hormone health and substance use disorders.
Petros’s current portfolio of men’s health products include the PDE-5 inhibitor drug Stendra® (avanafil) and the Timm Medical line of products. Stendra is an FDA- and EMEA-approved PDE-5 inhibitor drug used to treat erectile dysfunction. Stendra was initially launched in late 2013 and is patent protected through 2025. Timm Medical has a line of men’s health devices.
Petros trades on the Nasdaq Global Market under the ticker symbol “PTPI.”
Location: United States, New York
Investors 1
| Date | Name | Website |
| - | Juggernaut... | juggernaut... |
Mentions in press and media 15
| Date | Title | Description | Source |
| 13.07.2023 | Petros Pharmaceuticals Announces Capital Raise of $15 Millio... | - | accesswire... |
| 28.12.2021 | Petros Pharmaceuticals : Announces $7.5 Million Offering - F... | Petros Pharmaceuticals Announces $7.5 Million Offering December 22, 2021 Investors included the co... | marketscre... |
| 28.12.2021 | Petros Pharmaceuticals Announces Closing of $7.5 Million Off... | NEW YORK, Dec. 28, 2021 Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeut... | marketscre... |
| 22.12.2021 | Petros Pharmaceuticals Announces $7.5 Million Offering | NEW YORK, Dec. 22, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provi... | salamancap... |
| 22.12.2021 | Petros Pharmaceuticals Announces $7.5 Million Offering | NEW YORK, Dec. 22, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provi... | marketscre... |
| 02.12.2021 | Petros Pharmaceuticals Announces Closing of $10 Million Offe... | NEW YORK, Dec. 2, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provid... | salamancap... |
| 02.12.2021 | Petros Pharmaceuticals Announces Closing of $10 Million Offe... | NEW YORK, Dec. 2, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provid... | marketscre... |
| 02.12.2021 | Petros Pharmaceuticals : Announces $10 Million Offering - Fo... | Petros Pharmaceuticals Announces $10 Million Offering Investors included the company's largest shar... | marketscre... |
| 30.11.2021 | Petros Pharmaceuticals Announces $10 Million Offering | NEW YORK, Nov. 30, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provi... | marketscre... |
| 30.11.2021 | Petros Pharmaceuticals Announces $10 Million Offering | NEW YORK, Nov. 30, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provi... | salamancap... |
Show more